RxMx

RxMx is a digital health company that specializes in automating patient onboarding, monitoring, and safety management for high-touch specialty medicines. The company's platform connects patients, doctors, and laboratories to streamline the delivery of complex therapies, ensuring patient safety and regulatory compliance through real-time data integration. By automating clinical workflows and laboratory result monitoring, RxMx helps pharmaceutical companies launch and manage specialty drugs more efficiently. Following its acquisition by Appian in 2021, its technology has been integrated into broader low-code automation solutions for the life sciences industry. The platform is particularly effective for drugs requiring intensive monitoring, such as those in neurology, oncology, and rare disease markets.